ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News
Photo: Dr. Patrick Müller, LL.M., Partner at HEUKING in Düsseldorf (© P. Müller)

Late seed round for health tech start-up hellomed

Photo: Dr. Patrick Müller, LL.M., Part­ner at HEUKING in Düssel­dorf (© P. Müller)
2. July 2025

Düssel­dorf — The health tech start-up hello­med has raised a seven-figure late-seed finan­cing round. A seven-figure sum was inves­ted in the company in the finan­cing round by busi­ness angels and well-known family offices. The finan­cing round was imme­dia­tely follo­wed by an increase in share capital. 

The venture capi­tal (VC) team led by Düssel­­dorf-based HEUKING part­ner Dr. Patrick Müller has provi­ded legal advice to the health tech start-up hello­med Group GmbH on a late seed financing.

Foun­ded in 2022, Berli­ner GmbH is regis­tered in the Char­lot­ten­burg commer­cial regis­ter. It offers IT, marke­ting, HR, consul­ting and logi­stics services for phar­macies in the health­care sector and alre­ady descri­bes itself as the market leader for phar­macy solu­ti­ons in the field of profes­sio­nal care. 

With the hello­­med-OS-APP, prescrip­ti­ons can be conve­ni­ently trans­mit­ted online or reques­ted from the doctor. The tablets are then blis­te­red fully auto­ma­ti­cally in the clean room. Finally, the blis­ter packs are triple-checked — by means of a medi­ca­tion check using photo optics and by phar­macists. The pre-sorted pills are sent directly to the pati­ents at monthly or fort­nightly inter­vals. The app provi­des the care provi­ders with infor­ma­tion about the current medi­ca­tion status, the so-called range and auto­ma­tic follow-up prescrip­tion requests. 

HEUKING regu­larly advi­ses start-ups and VC inves­tors in various VC finan­cing rounds.

Advi­sor hello­med Group GmbH: HEUKING

Dr. Patrick Müller, LL.M. (Univer­sity of the West of England, Bris­tol), (lead), Düsseldorf,
Caro­line Frohn­wie­ser, Hamburg,
Laura Jochem, LL.M. (Univer­sity of East Anglia, Norwich), (all venture capi­tal), Düsseldorf

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de